Welcome to the UPF Digital Repository

Guidelines for the Evaluation and Treatment of Muscle Dysfunction in Patients With Chronic Obstructive Pulmonary Disease

Show simple item record

dc.contributor.author Barreiro Portela, Esther
dc.contributor.author Bustamante, Víctor
dc.contributor.author Cejudo, Pilar
dc.contributor.author Gáldiz, Juan B.
dc.contributor.author Gea Guiral, Joaquim
dc.contributor.author Lucas, Pilar de
dc.contributor.author Martínez-Llorens, Juana Mª
dc.contributor.author Ortega, Francesc
dc.contributor.author Puente-Maestu, Luis
dc.contributor.author Roca, Josep
dc.contributor.author Rodríguez-González Moro, José Miguel
dc.date.accessioned 2015-10-13T11:35:50Z
dc.date.available 2016-08-31T02:00:04Z
dc.date.issued 2015
dc.identifier.citation Barreiro E, Bustamante V, Cejudo P, Gáldiz JB, Gea J, de Lucas P. et al. Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 2015 Aug;51(8):384-95. doi: 10.1016/j.arbres.2015.04.011.
dc.identifier.issn 0300-2896
dc.identifier.uri http://hdl.handle.net/10230/24839
dc.description.abstract In patients with chronic obstructive pulmonary disease (COPD), skeletal muscle dysfunction is a major comorbidity that negatively impacts their exercise capacity and quality of life. In the current guidelines, the most recent literature on the various aspects of COPD muscle dysfunction has been included. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) scale has been used to make evidence-based recommendations on the different features. Compared to a control population, one third of COPD patients exhibited a 25% decline in quadriceps muscle strength, even at early stages of their disease. Although both respiratory and limb muscles are altered,the latter are usually more severely affected. Numerous factors and biological mechanisms are involved in the etiology of COPD muscle dysfunction. Several tests are proposed in order to diagnose and evaluate the degree of muscle dysfunction of both respiratory and limb muscles (peripheral), as well as to identify the patients’ exercise capacity (six-minute walking test and cycloergometry). Currently available therapeutic strategies including the different training modalities and pharmacological and nutritional support are also described.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.language.iso spa
dc.publisher Elsevier
dc.rights © 2014 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. http://dx.doi.org/10.1016/j.arbres.2015.04.011
dc.subject.other Pulmons -- Malalties obstructives -- Manuals, guies, etc.
dc.title Guidelines for the Evaluation and Treatment of Muscle Dysfunction in Patients With Chronic Obstructive Pulmonary Disease
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.arbres.2015.04.011
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking